Tag: biotechnology
-
Trial Begins for Advanced Covid-19 Disease Anti-Viral
A late-stage clinical trial is underway testing an oral anti-viral drug to treat moderate to severe cases of Covid-19 infections.
-
Challenge Seeks A.I. Antibody Enhancement Platform
A challenge competition is seeking computational biology teams to propose a new technology with artificial intelligence for enhancing antibody therapies.
-
University Lab Licenses Printed Kidney Tissue Process
A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure.
-
Synthetic SARS-CoV-2 Particle Designed for Drug R&D
Two biotechnology companies created a synthetic non-infectious target model to represent SARS-CoV-2 viral variants for vaccine and therapy developers.
-
Alzheimer’s Vaccine Shown to Produce Immune Response
In tests with lab animals, an experimental vaccine is shown to generate antibodies responding to toxic brain proteins associated with Alzheimer’s disease.
-
Start-Ups Partner on Quantum Computing and Longevity
Two companies formed in the last two years are applying quantum computing and artificial intelligence to discover new treatments for improving human longevity.
-
Health Breakthrough Research Group Doubles Funding
A not-for-profit organization that sponsors accelerated and high-impact health research worldwide says it gained a new $335 million in funding.
-
Start-Up Founders Demonstrate Amputated Tissue Regrowth
Founders of a regenerative medicine company demonstrated a drug delivery device that helps regrow several tissue types on frogs’ amputated limbs.
-
Infographic – Most of US Tries Plant Food Alternatives
A majority of respondents (58%) said they ate or drank at least one plant-based alternative to meat, fish, or dairy, while 42 percent said they did not.
-
Start-Up to Discover Proteins for Difficult Drug Targets
A new biotechnology company designing proteins in the lab for difficult drug targets in a range of diseases is raising $100 million in venture funds.